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Summary 
 
In sexual reproductive animals, the life begins from fertilized oocytes, which develop 
into the multicellular organism. In the process of development, the pattern of gene 
expression is dynamically changed. Prior to fertilization, the oocyte genome is not 
transcribed and this transcriptionally silent state is maintained for a while after 
fertilization. In mice, the gene expression is initiated at the mid-1-cell stage and the 
transcriptional activity is dramatically increased at the 2-cell stage. This activation of 
gene expression is called as zygotic gene activation (ZGA). The expression pattern in 
ZGA changes during DNA replication at the 2-cell stage. Previous studies using reporter 
genes revealed that transcription is stimulated by enhancers in the late 2-cell stage 
embryos but not 1-cell stage ones and that this enhancer independent gene expression 
was still observed at the late 2-cell stage when the DNA replication was inhibited. The 
pattern and regulation of gene expression is thus dramatically altered during the second 
round of DNA replication. Therefore, to distinguish the ZGA before and after the 
second round DNA replication, the former and later is called as minor and major ZGA, 
respectively. Although the function and regulatory mechanism of major ZGA has been 
well elucidated, those of minor ZGA have not been clarified.  
In chapter I, to explore the biological function of minor ZGA, I temporarily 
inhibited the transcription during minor ZGA using 5, 
6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB), a reversible inhibitor of RNA 
polymerase II, and analyzed the effect of the treatment with DRB on the 
preimplantation development. The majority of embryos treated with DRB were arrested 
at the 2-cell stage, uncovering that minor ZGA is essential for the development. To 
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further investigate the role of minor ZGA in the regulation of preimplantation 
development, I analyzed the gene expression using RNA sequencing in the 2-cell stage 
embryos after the removal of DRB. The results revealed that the temporal inhibition of 
transcription during minor ZGA resulted in the failure in major ZGA which is essential 
for the cleavage into the 4-cell stage. Thus, minor ZGA plays an essential role for 
occurrence of major ZGA. 
In chapter II, to find a key player of minor ZGA for embryonic development, I 
surveyed the transcription from intergenic regions, since a recent study suggested that 
the transcripts from protein-coding genes have no function at the 1-cell stage: they are 
not translated into functional proteins at this stage. The analysis of RNA sequencing 
revealed that intergenic regions were pervasively transcribed during minor ZGA, 
although the pervasive transcription was repressed during the second round of DNA 
replication. The analysis to find the upstream elements regulating the pervasive 
transcription suggested that G/C-rich regions are involved in the regulation of this type 
of transcription. The pervasive occurrence of intergenic transcription led me to the 
hypothesis that a non-coding RNA transcribed from the intergenic regions is involved in 
the regulation of preimplantation development. From RNA sequencing data and reverse 
transcription and polymerase chain reaction using preimplantation embryos and adult 
tissues, I found 4 species of RNAs which were transcribed from intergenic regions and 
expressed specifically in early preimplantation embryos. Reduction of the expression of 
these intergenic RNAs using LNA-DNA gapmers caused the developmental arrest 
before the blastocyst stage. These results suggested that intergenic non-coding RNAs 
which are transcribed during minor ZGA are involved in the regulation of 
preimplantation development.  
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    Taken together, I provided the evidence that minor ZGA has a critical function for 
preimplantation development through the activation of the subsequent major ZGA. This 
transcriptional cascade from minor to major ZGA may be regulated by intergenic RNAs 
which are transcribed during minor ZGA.  
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General introduction 
 
Life arises from a single cell, i.e. a zygote. The development from zygotes to the 
adult multicellular organisms is achieved through the changes in gene expression 
patterns. Before fertilization, mouse oocytes express the genes, including 
oocyte-specific genes, e.g. Zp3 and c-Mos, in a specific pattern. During their growth, 
mRNA is highly stable and accumulated in the cytoplasm as maternal mRNAs (Schultz, 
1993; Yu et al., 2003). However, their transcription ceases near the time when the 
oocytes grow into their full size and the transcriptionally silenced state continues during 
meiosis and even after fertilization (Moore et al., 1974; Aoki et al., 1997; Abe et al., 
2010). Therefore, the accumulated maternal mRNA supports the meiosis progression 
and the development of embryos for a while after fertilization. In the earlier studies, the 
initiation of transcription from zygotic genes, which was designated as zygotic gene 
activation (ZGA), was considered to occur at the 2-cell stage but not at 1-cell stage in 
mice, because gel electrophoresis analyses of the proteins incorporating [
35
S]methionine 
showed that the protein synthesis pattern did not change until 2-cell stage after 
fertilization. However, soon after cleaved into 2-cell stage, a few proteins which had not 
been observed in the oocytes or 1-cell stage embryos appeared (van Blerkom and 
Brockway, 1975). Addition of -amanitin, a potent inhibitor of RNA polymerase II (Pol 
II), prevented or reduced the appearance of these proteins (Levey et al., 1978). 
Therefore, these proteins, whose molecular weight was ~70 kd, were considered as the 
products derived from the transcripts in ZGA and designated as transcription requiring 
complex (TRC) (Conover et al., 1991). The gel electrophoresis analysis of the newly 
synthesized proteins also revealed that the protein synthesis patterns dramatically 
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changed during S phase of the 2-cell stage, suggesting that the gene expression patterns 
grossly alters at this time (Flach et al., 1982; Bolton et al., 1984). Therefore, this burst 
of zygotic gene activation at mid to late 2-cell stage was designated as major ZGA to 
discriminate from minor ZGA transcribing mRNAs encoding TRC, the initial 
transcription from zygotic genome, at the early 2-cell stage (Flach et al., 1982).  
Although in these pioneering studies, the transcription from zygotic genes was not 
detected before 2-cell stage, the later studies using more sensitive assays, i.e. BrUTP 
incorporation and the expression of a plasmid reporter genes, revealed that the 
transcription from zygotic genes begins at the S phase of 1-cell stage (Matsumoto et al., 
1994; Aoki et al., 1997). Therefore, it is now recognized that minor ZGA occurs 
between S phase of the 1-cell stage and G1 phase of the 2-cell stage.  
The second round of DNA replication is involved in the transition of the gene 
expression patterns from minor to major ZGA. Two-dimensional gel electrophoresis and 
mRNA differential display identified the markers for minor ZGA, i.e. TRC, Hsp70 and 
Eif1a (Bensaude et al., 1983; Conover et al., 1991; Davis et al., 1996). The expression 
of these minor ZGA markers were repressed at the late 2-cell or 4-cell stage but 
remained high when the second round of DNA replication was inhibited by aphidicolin 
which is the inhibitor of DNA polymerase (Ohashi et al., 1978). These reports suggested 
that minor ZGA is repressed by the second round of DNA replication, resulting in the 
transition of the gene expression pattern from minor ZGA into major ZGA. In addition, 
it has also been shown that the second round of DNA replication is implicated in the 
changes in the regulation of gene expression during the transition from minor ZGA into 
major one. Generally, enhancers activate the repressed promoters. However, the 
activation of promoters by enhancers was not observed before 2-cell stage after 
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fertilization (Wiekowski et al., 1991; Majumder et al., 1993; Majumder and 
DePamphilis, 1995; Lawinger et al., 1999). The expression of reporter gene was 
stimulated by an enhancer in 2-cell stage embryos, but not at the 1-cell stage. When the 
second round of DNA replication was inhibited by aphidicolin, the expression of reporter 
gene was not stimulated by an enhancer at even the late 2-cell stage (Majumder et al., 
1993; Henery et al., 1995; Majumder et al., 1997; Forlani et al., 1998). The second round 
of DNA replication thus changes the regulation of gene expression from the 
enhancer-independent manner in minor ZGA into the enhancer-dependent one in major 
ZGA.   
   The requirement for enhancers seems to be regulated by the chromatin structure in 
the early embryos. In the late 2-cell stage embryos treated with butyrate, a histone 
deacethylase inhibitor that loosens the chromatin structure, the expression of injected 
reporter genes were actively expressed by a promoter and not stimulated by an enhancer 
as in 1-cell stage embryos and the late 2-cell stage embryos whose DNA replication had 
been inhibited by aphidicolin (Majumder et al., 1993; Majumder and DePamphilis, 
1995; Majumder et al., 1997; Lawinger et al., 1999). These results suggested that the 
loosened chromatin structure is involved in the enhancer-independent transcriptional 
regulation in minor ZGA. 
Minor ZGA is the first gene expression after fertilization, but this biological 
function has not been clarified. It has been thought that major ZGA is required for the 
embryonic development but not minor ZGA, because the embryos were cleaved into 
2-cell stage and then arrested at the G2 phase of 2-cell stage when they had been 
cultured in the presence of -amanitin from the time just after fertilization (Warner and 
Versteegh, 1974). However, this experiment is insufficient to prove that minor ZGA is 
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not essential for embryonic development, since it is possible that 1-cell stage embryos 
could accomplish the first cell cycle by using the proteins translated from the 
accumulated maternal mRNAs and that zygotic transcripts derived from minor ZGA are 
required for the progression of the second cell cycle. To clarify the biological function 
of minor ZGA, it is required to inhibit only minor ZGA but not subsequent 
transcriptions.  
   Previous studies have suggested the specific mechanisms regulating minor ZGA. 
However, most of those results were obtained by reporter gene assays using exogenous 
promoters and enhancers. To investigate the transcriptional regulation in minor ZGA, 
the analysis for the endogenous cis-acting elements involved in minor ZGA would be 
essential. However, although several reports showed the results of the microarray 
analysis for the changes in gene expression patterns during preimplantation 
development and suggested the cis-acting elements regulating the gene expression in 
major ZGA at the 2-cell stage and thereafter (Hamatani et al., 2004; Wang et al., 2004), 
little is known about such elements in minor ZGA because the small number of 
transcribed regions are known in minor ZGA. The reason comes from the fact that the 
amount of mRNA transcribed in minor ZGA is small and masked by a large amount of 
accumulated maternal mRNA in the analysis of microarray. To analyze endogenous 
cis-elements, it is required to sensitively detect a small amount of zygotic transcripts in 
minor ZGA. 
Recent RNA sequencing (RNA-seq) technology is known as alternative approach 
for microarray on genome wide transcriptome analysis. RNA-seq is more precise and 
quantitative method than microarray (Xiong et al., 2010). Therefore, this method is 
promising approach to detect zygotic transcripts whose amounts are quite lower than 
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maternal ones. Furthermore, RNA-seq technology allows the detection of intergenic 
transcripts. Previous microarray analyses did not carry comprehensive information on 
gene expression profiles in 1-cell stage embryos, because they used the probes which 
targeted annotated genes only. Emerging evidence has revealed that a long non-coding 
RNA transcribed from intergenic regions plays important role in the regulation of gene 
expression in the various types of cell ( Loewer et al., 2010; Zhao et al., 2010; Cabili et 
al., 2011; Cesana et al., 2011; Grote et al., 2013; Klattenhoff et al., 2013). However, 
little is known about these RNAs transcribed in minor ZGA. RNA-seq would be the 
best method to obtain the information about them. 
   In this thesis, I investigated the function and the mechanism regulating minor ZGA. 
In chapter I, to elucidate the biological function of minor ZGA, I inhibited only minor 
ZGA using DRB, a reversible inhibitor of RNA polymerase II (Zandomeni et al., 1986; 
Raju et al., 1991), and examined the effect of inhibition of minor ZGA in the 
preimplantation development. I also analyzed the gene expression after the temporal 
inhibition of minor ZGA to examine its involvement in the regulation of major ZGA. In 
chapter II, to find an functional element of minor ZGA, I surveyed an intergenic RNA 
specifically transcribed during minor ZGA using RNA-seq and investigated their roles 
in the preimplantation development. In addition, I also found the unique transcription 
feature of minor ZGA by whole genome transcriptome analysis using RNA-seq. To 
explore the mechanism regulating this transcription during minor ZGA, I examined the 
cis-elements of transcribed regions.  
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Result 
 
Inhibition of the transcription during minor ZGA by DRB 
To investigate the involvement of minor ZGA in the regulation of preimplantation 
development, I used DRB to inhibit the transcription during minor ZGA. Since DRB is 
a reversible inhibitor for RNA polymerase II dependent transcription, the transcriptional 
activity is recovered after its removal (Raju et al., 1991), implying that DRB could 
inhibit the transcription solely during the phase of minor ZGA by removing the drug 
from a medium soon after the termination of minor ZGA phase. Since the transition 
from the phase of minor ZGA to that of major ZGA occurs during the second round of 
DNA replication (Flach et al., 1982; Bolton et al., 1984), DRB should be removed at the 
time of the occurrence of DNA replication. Therefore, I first investigated the time of 
initiation of DNA replication at the 2-cell stage by the incorporation of BrdU. I found 
that most embryos reached to S phase at 20 h after insemination (Fig. 2A). Since 
previous study showed that minor ZGA starts around the mid-S phase of 1-cell stage 
(Aoki et al., 1997), I decided to treat the embryos with DRB from G1 phase of 1-cell 
stage (4 h after insemination) until G1 phase of 2-cell stage (20 h after insemination). To 
determine the minimum effective concentration of DRB, I examined the transcriptional 
activity by the incorporation of BrU in the 1-cell stage embryos treated with various 
concentrations of DRB (0, 20, 40, 60, 80 and 100 M). The transcriptional activity 
decreased along with the increase in the concentration of DRB until 80 M, and the 
inhibitory effect on the transcription plateaued over this concentration (Fig. 2B). Thus, I 
decided to treat the embryos with 80 M of the drug as its minimum effective 
concentration on the inhibition of minor ZGA.  
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To verify the reactivation of the transcription after the removal of DRB, I 
examined the transcriptional activity by the incorporation of BrU in the 1-cell and 2-cell 
stage embryos during and after the treatment with DRB. In the absence of DRB, all 
embryos exhibited active transcription. However, the embryos treated with DRB 
showed no or little transcriptional activity (Fig. 2C). When the embryos which had been 
treated with DRB were transferred to the medium without DRB, the transcription was 
activated 1 h after the transfer. In addition, I also observed the phosphorylation on 
C-terminal domain (Ser2P) of Pol II which is associated with transcriptional elongation, 
since DRB represses the transcription through inhibiting the activity of protein kinases 
that target Pol II. Immunocytochemistry with the antibody against Ser2P revealed that 
the signal of fluorescence was not detected in the embryos when they were treated with 
DRB and then appeared 1 h after the transfer to the medium without DRB (Fig. 2D), 
indicating again that the transcription did not occur in the embryos treated with DRB 
and started soon after the removal of the drug. To further ascertain the inhibitory effect 
of DRB on transcription, I conducted RT-PCR in the 1-cell stage embryos treated with 
DRB to examine the expression level of the genes which are transcribed during minor 
ZGA. I confirmed that the expression levels of all genes examined were markedly 
reduced by the treatment with DRB (Fig. 2E).  
 
Involvement of minor ZGA in the regulation of preimplantation development 
The embryos were transferred to the medium containing DRB 4 h after 
insemination, and then they were moved to DRB-free medium 20 h after insemination 
and cultured until 96 h. In the control embryos which had not been treated with DRB, 
98% of them cleaved to 3-4 cell or 6-8 cell stages. Thereafter, 94% and 92% of the 
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embryos developed to the molura and blastocyst stages 72 h and 96 h after insemination, 
respectively (Fig. 3A and 3B). However, most of the embryos treated with DRB were 
arrested at the 2-cell stage 46 h after insemination. At 96 h, more than 60 % of them 
were still arrested at 2-cell stage and only 10 % of the embryos reached the blastocyst 
stage. To examine the phase of cell cycle at which those embryos were arrested at the 
2-cell stage, I examined the occurrence of DNA replication in DRB-treated embryos by 
the incorporation of BrdU 26 h after insemination. They incorporated BrdU as was 
observed in the control embryos (Fig. 3C). Since the nuclei was clearly observed in the 
arrested embryos (data not shown), they had not entered into M phase. Therefore, the 
embryos were arrested at G2 phase of the 2-cell stage. 
To assess the effect of the inhibition of major ZGA in the preimplantation 
development, the embryos were treated with DRB from 26 to 42 h after insemination. 
70% of them cleaved to 3-4 cells, but 30% of them remained at the 2-cell stage (Fig. 
3A). However, the percentage of the embryos at 2-cell stage decreased to 6%, and that 
of the embryos which had developed beyond 2-cell stage increased to 93% 72 h after 
insemination. At 96 h, more than 40% and 30% of the embryos reached the morula and 
blastocyst stage, respectively. Thus, the rate of development was retarded but the 
developmental potential remains by the temporal inhibition of major ZGA, although the 
potential was completely lost by the inhibition of minor ZGA. These results suggest that 
the timely occurrence of minor ZGA but not major one is essential for the 
preimplantation development. 
 
Effect of temporal inhibition of minor ZGA on the gene expression at the late 2-cell 
stage 
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To investigate the cause of 2-cell-arrest in the embryos in which minor ZGA were 
inhibited with DRB, I examined the gene expression at the late 2-cell stage after the 
removal of DRB. Firstly, I measured the transcriptional activity by the incorporation of 
BrU. After the removal of DRB, the transcriptional activity drastically increased. It was 
much higher than that in the control embryos without the treatment with DRB until 29 h 
after insemination. However, the activity started decreasing from 29 h, and it became to 
be lower than the control embryos 32 h and continued to decrease until 96 h after 
insemination (Fig. 4). These results suggested that the Pol II paused around promoter 
regions by DRB was rapidly reactivated soon after the removal of DRB, and the genes 
expressed during this period would make a detrimental effect on the subsequent gene 
expression: An aberrant gene expression different from the programmed one would 
occur after the removal of DRB. 
To investigate the effect of inhibition of minor ZGA on the gene expression after 
the removal of DRB, I conducted RNA sequencing for the DRB-treated 2-cell stage 
embryos 12 h after the removal of DRB (32 h after insemination) and compared the 
expression levels of genes between DRB-treated and -untreated embryos. In this 
analysis, it was useful to extract the genes that are transcribed during minor and major 
ZGA and then examine the effect of temporal inhibition of minor ZGA in their 
expression. Therefore, I classified the genes by the changes of their expression levels at 
the oocyte, 1-cell and 2-cell stages using a k-means nonhierarchical clustering method 
(Saeed et al., 2003). When the genes were categorized into five classes, cluster I 
consisted of the genes whose expression levels did not change after fertilization 
(between oocyte and 1-cell stage) but increased at the 2-cell stage, indicating that this 
cluster mostly contained the genes transcribed during major ZGA but not minor ZGA 
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(Fig. 5A). The genes classified into cluster II decreased their expression levels after 
fertilization but increased at the 2-cell stage, which indicates that this cluster also 
contains the genes transcribed during major ZGA but not minor ZGA as well as cluster I. 
The cluster III consisted of the genes which continuously decreased their expression 
levels after fertilization and the cleavage into 2-cell stage. The genes in this class did not 
seem to be activated during any of minor and major ZGA. Cluster IV mostly contains 
the genes whose expression levels increased after fertilization and then further increased 
at the 2-cell stage, indicating that they are transcribed during both of minor and major 
ZGA. Finally, the genes in cluster V increased their expression levels after fertilization 
and decreased at the 2-cell stage. The genes in this cluster seemed to be transcribed 
during minor ZGA but not major one. When the expression levels were compared 
between the embryos treated with and without DRB, more than half of the genes in 
cluster I and II, which were transcribed during only major ZGA but not minor one, 
decreased their expression levels after the removal of DRB (Fig. 5A). On the contrary, a 
large part of the genes in cluster IV and V, which were transcribed during minor ZGA, 
increased their expression after the removal of DRB. The similar results were obtained 
when the numbers of highly up-regulated and down-regulated genes were examined in 
each cluster (Fig. 5B). In cluster I and II, the numbers of down-regulated genes were 
higher than those of up-regulated ones. On the contrary, in cluster IV and V, the 
numbers of up-regulated genes were much higher. These results indicated that a large 
part of genes which are supposed to be transcribed during minor ZGA were activated 
after the removal of DRB, but that those transcribed during major ZGA were not 
sufficiently transcribed at the time (32 h after insemination) when major ZGA normally 
occurs. Therefore, it is possible that the deficient expression of genes which are 
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transcribed during major ZGA caused the arrest of DRB-treated embryos at 2-cell stage: 
it was shown that major ZGA is essential for 2-cell stage embryos to cleave into 4-cell 
stage (Warner and Versteegh, 1974). To address this hypothesis, I examined the 
expression of the genes which play important roles in the regulation of cell cycle in 
DRB-treated embryos. Because it has been supposed that the embryos treated with DRB 
were arrested at G2 phase of 2-cell stage (Fig. 3C), I focused on the genes which are 
involved in G2/M transition. I found that all of Ccna2, Cdk1 and Cdc25c, whose 
encoding proteins are essential components of M-phase promoting factor and its 
activator (Hutchins and Clarke, 2004; Wang et al., 2011; Wolgemuth, 2011), belonged to 
cluster I (Fig. 6) and their expression was reduced by the treatment with DRB (Fig. 6). 
These results suggested that the reduction of the expression of these genes caused the 
developmental arrest in the DRB-treated embryos. Taken together, I suggest that the 
temporal inhibition of minor ZGA caused the deficient activation of the cell 
cycle-related genes which are set to be expressed during major ZGA, leading to the 
developmental arrest of DRB-treated embryos.  
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Discussion 
 
Previous studies using micro array revealed that the pattern of gene expression is 
dynamically changed during preimplantation development (Hamatani et al., 2004; Wang 
et al., 2004; Kageyama et al., 2007). It is thought that this change is precisely controlled 
under a program of gene expression. However, it has not been clarified how strict 
timing of the expression at each developmental stage is required for the normal 
progression of the program. In the present study, I have shown that the temporal 
inhibition of minor ZGA caused the failure in major ZGA and the developmental arrest 
at the 2-cell stage, although a large number of genes which are supposed to be 
transcribed during minor ZGA were expressed after the removal of DRB (Fig. 5A and 
B). This result suggested that major ZGA requires the occurrence of minor ZGA at an 
appropriate time. On the contrary, when major ZGA was inhibited by the treatment with 
DRB, 70% of embryos successfully developed to the morula and blastocyst stages (Fig. 
3A), implying that major ZGA occurred after the removal of DRB. Taken together, my 
results suggested that the gene expression program is strictly regulated by the stage 
specific manner during minor ZGA but not major one.  
During the treatment with DRB, the transcriptional machineries containing Pol II 
possibly remained to be bound to the promoters of the genes which were supposed to be 
transcribed during minor ZGA, because DRB represses transcriptional elongation 
through the inhibition of phosphorylation of Pol II (Chodosh et al., 1989; Dubois et al., 
1994; Larochelle et al., 2012). Therefore, the transcriptional machineries bound to 
around promoter regions seemed to rapidly resume the transcriptional elongation after 
the removal of DRB, resulting in the activation of genes which were supposed to be 
22 
 
transcribed during minor ZGA but not major ZGA at the 2-cell stage. Supporting this 
hypothesis is that the transcriptional activity was markedly increased soon after the 
removal of DRB (Fig. 4). Since most of Pol II molecules would be stuck around the 
promoter regions without moving away to transcribe the coding regions during the 
treatment with DRB, the burst of transcription might occur by the concurrent activation 
of those stuck Pol II after the removal of DRB. 
The temporal inhibition of minor ZGA caused the developmental arrest at G2 
phase of the 2-cell stage (Fig. 3C). Although a group of genes which are supposed to be 
transcribed during minor ZGA were activated soon after the removal of DRB (cluster IV 
and V in Fig. 5A and B), a majority of the genes transcribed during major ZGA were not 
activated (cluster I and II in Fig. 5A and B). Therefore, it seemed that the developmental 
arrest was due to the deficient expression of the genes which are essential for the 
progression of cell cycle from G2 to M phase. Indeed, the expressions of various cell 
cycle-related genes were reduced by the treatment with DRB (Fig. 6). Alternatively, it is 
also possible that the expression of the genes of minor ZGA at the late 2-cell stage had a 
detrimental effect on the regulation of cell cycle progression. A recent study reported 
that most of genes are transcribed at the 1-cell stage. If these transcripts are translated 
into proteins, such an unregulated expression of the proteins would have detrimental 
effects on the progression of cell cycle. However, the majority of mRNAs transcribed at 
the 1-cell stage were not translated into functional proteins because they were not 
spliced (Yamamoto et al., 2012). When the genes which are supposed to be transcribed 
during minor ZGA were activated after the removal of DRB, they would be spliced and 
translated into proteins which might have an adverse impact on the regulation of cell 
cycle at the late 2-cell stage.  
23 
 
 
 
24 
 
 
 
 
25 
 
 
 
 
 
 
 
 
26 
 
 
 
27 
 
 
 
 
 
 
 
 
 
 
 
 
28 
 
 
 
 
 
 
Chapter II 
 
The exploration of functional factors and 
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Result 
 
Pervasive transcription from intergenic regions during minor ZGA 
It has been reported that the transcripts are not spliced at the 1-cell stage (Yamamoto et 
al., 2012), indicating that functional proteins are not synthesized from these transcripts. 
Therefore, I focused on the transcripts from intergenic regions, since recent emerging 
evidence revealed that long intergenic non-coding RNA (lincRNA; Guttman et al., 
2009) and small RNAs, e.g. siRNA, miRNA and piRNA, transcribed from non-coding 
regions have specific functions on various biological processes (Cieśla et al., 2014; 
Dogini et al., 2014).  
First, I analyzed the genome wide expression from intergenic regions. When I 
overviewed the transcribed regions on the whole genome, I found that a pervasive 
transcription occurs in the intergenic regions of 1-cell stage embryos (Fig. 7A). To 
confirm it quantitatively, I divided the intergenic regions across the entire genome into 
1-kb sequences and enumerated divided regions in which at least a single read was 
mapped uniquely. The number of mapped regions was threefold higher in 1-cell stage 
embryos than oocytes (Fig. 7B). In the embryos at the late 2-cell stage, the number of 
mapped regions was smaller than that of 1-cell stage embryos and it decreased gradually 
with development and reached levels similar to those of oocytes at the morula stage. 
When 1-cell stage embryos were treated with DRB, the number of mapped regions 
remained similar to that in oocytes (Fig. 7C). These results suggested that pervasive 
transcription occurs in the intergenic regions during minor ZGA, but that this was 
repressed after the occurrence of major ZGA.  
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Involvement of intergenic RNAs transcribed during minor ZGA in the 
preimplantation development 
Since it was reported that some lincRNAs function without being spliced (Hutchinson et 
al., 2007), it was possible that a lincRNA(s) was involved in the preimplantation 
development. To identify it (them), I investigated the intergenic RNAs which are 
specifically expressed at the 1-cell stage. Since previous study showed that lincRNA 
contains evolutionary conserved sequences which are predicted as functional domains 
(Guttman et al., 2009), I sought for the intergenic RNAs which contained evolutionary 
conserved sequences and were specifically expressed in 1-cell stage embryos. I first 
selected the intergnic regions mapped by one or more reads at the 1-cell stage but not 
other embryonic stages using RNA sequence data, and then examined whether or not 
those regions contain the sequences conserved among humans, mice, dogs and horses 
by using multiple alignments data of UCSC genome browser (Fig. 8A). By this primary 
selection, I obtained 25 candidates for lincRNA specifically expressed at the 1-cell stage. 
To further confirm the specific expression of these candidates at the 1-cell stage, I 
examined their expression in oocytes, preimplantation embryos and adult tissues by 
RT-PCR. The results showed that 4 species of intergenic RNAs were specifically 
expressed at the 1-cell stage (Fig. 8B). Intriguingly, these candidates for lincRNA were 
not registered in RNA db, the data base for non-coding RNA. To assess which strands 
are transcribed for these candidates, I conducted RT-PCR in which reverse transcription 
was performed using primers specifically binding to plus or minus strand in intergenic 
RNAs coding regions. The candidates, linc-1, 2, 3 and 4 were transcribed from plus, 
minus, plus and minus strands, respectively (Fig. 8C). Since the candidate RNAs might 
contain an open reading frame that is translated into a functional protein, I evaluated the 
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protein coding potential in the above-mentioned conserved sequences in the candidates, 
using Coding Potential Calculator (Kong et al., 2007). The result indicated that all of 4 
candidates had a high potential for non-coding. Thus, it was very likely that the 
intergenic RNA that I had identified were novel lincRNAs specifically expressed at the 
1-cell stage. 
To assess whether 1-cell specific intergenic RNAs are required for the 
preimplantation development, their expression was reduced by LNA-DNA gapmers 
which had been reported to successfully reduce major satellite transcripts in 
preimplantation embryos (Probst et al., 2010). I injected into 1-cell stage embryos with 
two different sequences for each of 4 intergenic RNAs (linc-1, 2, 3 and 4). All of these 
gampers, except for the second one (gapmer B) targeting linc-4, successfully reduced 
the expression of their target RNAs (Fig. 9A). When non-targeting control gapmers or 
gapmers targeting a lincRNA which was not expressed at the 1-cell stage was injected, 
more than 80% of embryos developed to the blastocyst stages (Fig. 9B). However, the 
reduction of development was observed in the embryos which had been injected with 
the gapmers targeting any of linc-1-4. Only 30% or less embryos developed to the 
blastocyst stage (Fig. 9B). These results suggested that 1-cell specific intergenic RNAs 
were essential for embryonic development. 
 
Regulation of pervasive transcription from intergenic regions 
    It is likely that pervasive transcription from intergenic regions is associated with 
the transcriptionally permissive state before the second round of DNA replication. 
Previous studies using reporter gene assays demonstrated that 1-cell stage embryos are 
in a transcriptionally permissive state, in which enhancers are not required for gene 
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expression, and that a transcriptionally repressive state requiring enhancers is 
established during DNA replication at the 2-cell stage (Nothias et al., 1995). When the 
DNA replication was inhibited, the enhancer independent transcription still occurred in 
2-cell stage embryos (Wiekowski et al., 1993; Henery et al., 1995). This 
transcriptionally permissive state allowed for promiscuous expression without an 
enhancer from the intergenic regions during minor ZGA; establishment of the repressive 
state suppressed promiscuous expression during major ZGA. To address this hypothesis, 
we inhibited DNA replication in 2-cell stage embryos by treatment with aphidicolin, an 
inhibitor of DNA polymerase, and analyzed the RNA sequencing data and transcription 
from intergenic regions. We found that the pervasive transcription from intergenic 
regions still occurred in the embryos at the late 2-cell stage in which DNA replication 
was inhibited; the number of transcribed intergenic regions was higher in 2-cell stage 
embryos treated with aphidicolin than in 1-cell stage embryos (Fig. 10A). To confirm 
the association of the permissive state with intergenic transcription during minor ZGA, 
we selected intergenic regions to which a number of reads were uniquely mapped in 
1-cell stage embryos but not oocytes, and examined their expression by RT-PCR. We 
first confirmed that transcription of these two intergenic regions occurred only in 1-cell 
stage embryos but not in oocytes or 1-cell stage embryos treated with DRB (Fig. 10B). 
Their expression levels decreased at the 2-cell stage but remained high upon inhibition 
of DNA replication by aphidicolin (Fig. 10C).  
Taken together, these results suggested that a transcriptionally permissive state 
allows for promiscuous expression from the intergenic regions during minor ZGA, and 
that establishment of the repressive state, which is coupled to DNA replication, 
suppresses promiscuous expression.    
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Core-promoter-element-independent pervasive transcription in minor ZGA 
Since transcription requires core promoter elements in eukaryote cells, I analyzed which 
elements are involved in pervasive transcription from intergenic regions. I examined the 
presence of DPE, Initiator (Inr), CCAAT, TATA box, BRE and GC box in 500 bp 
upstream and 100 bp downstream of transcribed intergenic regions. Although DPE, Inr 
and CCAAT were present at a high rate, a similar result was obtained in randomly 
selected 600 bp regions from untranscribed intrgenic regions (Fig. 11A), suggesting that 
pervasive intergenic transcription is not caused by a particular core promoter element. 
In mammalian somatic cells, the promoter regions of many genes have a high G/C 
content (Sandelin et al., 2007; Fenouil et al., 2012). In addition, previous reporter gene 
experiments using a vector without any insertion of promoter sequences showed that 
transcription occurred independently of known core promoter elements but is associated 
with high G/C content regions in 1-cell stage embryos (Cao et al., 2013). Therefore, to 
investigate whether or not the sequences with high G/C content are associated with the 
pervasive transcription from the intergenic regions, I counted the number of transcribed 
regions around the G/C-rich regions using RNA sequence data. The number of 
transcribed 1 kb upstream and downstream of G/C-rich (more than 60%) regions were 
the largest in the 1-cell stage embryos (Fig. 11B), suggesting that transcription occurs 
around G/C-rich regions at the higher rate in 1-cell stage embryos. Thus, G/C-rich 
regions seem to be associated with the pervasive transcription observed in 1-cell stage 
embryos.  
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Discussion 
 
    In this study, I found that pervasive transcription occurs in intergenic regions. Thus, 
many functional non-coding RNAs are likely produced during minor ZGA. A recent 
study demonstrated that newly synthesized mRNAs are hardly translated into functional 
proteins at the 1-cell stage because of the deficiency of splicing machinery (Yamamoto 
et al., 2012). Recent emerging evidence revealed that non-coding RNAs play key roles 
in various biological processes and that some non-coding RNAs function without 
undergoing splicing, e.g. siRNA, miRNA, piRNA and some lincRNAs (Hutchinson et 
al., 2007; Cieśla et al., 2014; Dogini et al., 2014). It was reported that some of these 
non-coding RNAs are involved in the regulation of gene expression and that siRNA has 
important functions for preimplantation development (Tam et al., 2008). In addition, I 
found that intergenic RNAs which are transcribed specifically at the 1-cell stage and the 
candidates for novel lincRNAs were essential for preimplantation development (Fig. 
9B). Intriguingly, the present study demonstrated that minor ZGA is indispensable for 
the activation of subsequent major ZGA (Chapter I). Therefore, the intergenic RNAs 
identified in my study may play a key role in the alteration of the regulatory mechanism 
for gene expression from minor ZGA into major one. It has been reported that some 
lincRNAs involve transcription through epigenetic modifications and the interaction 
with transcription factors (Zhao et al., 2010; Bergmann and Spector, 2014; Wang et al., 
2014). Intergenic RNAs transcribed during minor ZGA may contribute to activation of 
the transcription factors or change the epigenetic status for occurrence of major ZGA. In 
addition, it was reported that HOTAIR, a lincRNA, was associated with the degradation 
of Ataxin-1 and Snurportin-1 through an ubiquitin-proteasome pathway (Yoon et al., 
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2013). Thus, novel intergenic RNAs may be involved in the rapid degradation of the 
proteins that are involved in the oocyte-specific phenomenon, e.g. meiosis, but make 
detrimental effects on the preimplantation development after fertilization.  
I have shown that all of four intergenic RNAs which I had identified were essential 
for preimplantation development (Fig. 9B). I prepared two types of LNA-DNA gampers 
with different sequences for each of these four intergenic RNAs, and found that the 
injection of any of these gampers caused the reduction of preimplantation development. 
However, in the embryos injected with the gapmers against linc-3 and -4, the patterns of 
the reduction were inconsistent between the two types of gapmers. In the experiments 
for the knock-down of linc-4, the embryos injected with gapmer 4A showed the 
reduction of development at the 4-cell stage. However, those with gapmer 4B did not 
show any reduction at this stage, and they develop to the morula stage but not the 
blastocyst one (Fig. 9B). This different phenotypes between gapmer 4A and B seems to 
be caused by the efficiency of reduction of target RNA. The injection of gapmer 4A 
successfully reduced the expression of linc-4, whereas gapmer 4B caused the moderate 
reduction (Fig. 9A). In the experiments in which linc-3 was targeted, although the 
efficiency of reduction was at the same level between the embryos injected with gapmer 
3A and 3B (Fig. 9A), the reduction of development was severer in the embryos injected 
with gapmer 3B: the embryos injected with gapmer 3B showed the reduction at the 
4-cell stage, whereas those with gapmer 3A developed to the morula stage (Fig. 9B). 
After the hybridization of LNA-DNA gapmers with their target RNA, they are sliced by 
RNase H (Braasch and Corey, 2001). The sliced RNA that bound to gapmer A might 
still have the function which supported the development to the morula stage.  
The pervasive transcription is likely caused by the loosened chromatin structure 
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during minor ZGA. Generally, chromatin structure is repressive for transcription. 
Enhancers are required by transcription factors to be accessible to promoters in 
repressive chromatin. However, previous studies suggested that transcription is 
regulated independently of enhancers at the 1-cell stage (Wiekowski et al., 1991; 
Majumder et al., 1993; Schultz, 1993). It is known that the chromatin is decondensed 
and heterochromatin domains are present only in the peripheral regions of nucleolei in 
the embryos at the 1-cell and early 2-cell stages (Akiyama et al., 2011). A previous 
study showed that the genome DNA was more sensitive to DNase I at the 1- than the 
late 2-cell stage, suggesting that the chromatin is loosened in the 1-cell stage embryos 
(Cho et al., 2002). Therefore, this loosened chromatin structure seems to enable 
transcription factors to access to the promoters without the involvement of enhancers. In 
the present study, I have shown that various core promoter elements are present on the 
upstream of intergenic regions transcribed at the 1-cell stage, but that these elements are 
also found in the randomly-selected regions (Fig. 11A), which would deny the 
hypothesis that a core promoter element is responsible for the pervasive intergenic 
transcription. Since the areas around G/C-rich regions were transcribed at a high rate in 
the 1-cell stage embryos (Fig. 11B), these regions may be involved in the regulation of 
pervasive transcription.     
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General discussion 
 
In this thesis, I have shown two important findings about minor ZGA. The first one is 
the significance of minor ZGA in the regulation of development. It has been known that 
minor ZGA occurs in various species. However, the biological significance and 
mechanism of this gene expression has not been clarified, because it has been thought 
that minor ZGA is dispensable for the regulation of development. The embryos in which 
minor ZGA were inhibited by α-amanitin, an irreversible Pol II inhibitor, cleaved into 
2-cell stage followed by DNA replication and then arrested at G2 phase (Warner and 
Versteegh, 1974), which led to the idea that major ZGA but not minor ZGA is essential 
for the regulation of preimplantation development. However, in my study, I inhibited 
minor ZGA temporarily by using DRB, a reversible inhibitor, and obtained the first 
evidence that minor ZGA is indispensable for embryonic development through the 
activation of subsequent major ZGA.  
The second important finding in this thesis is that intergenic regions are 
pervasively transcribed during minor ZGA and that several species of RNAs transcribed 
from those regions are involved in the regulation of preimplantation development. 
Previous analyses using microarray (Hamatani et al., 2004; Wang et al., 2004) or RNA 
sequencing (Park et al., 2013; Xue et al., 2013) have not provided any information 
about this unique transcription from intergenic regions during minor ZGA, because the 
probes of micro arrays in the previous analyses targeted only known gene regions and 
the recent RNA sequencing analysis focused on only known protein coding or annotated 
non-coding regions but not global intergenic regions. However, the present analysis of 
RNA sequencing explored unknown intergenic regions. Thus, my study is the first 
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report which has shown the unique mechanism of transcriptional regulation in 
intergenic regions during minor ZGA. 
Several studies suggested that the chromatin structure at the 1-cell stage is looser 
than that at other embryonic stages (Cho et al., 2002; Ahmed et al., 2010). Although the 
loosened chromatin structure seems to induce pervasive transcription during minor 
ZGA, the mechanism of decondensation in the chromatin of 1-cell stage embryos is 
unknown. It is known that the chromatin structure is regulated by chromatin remodeling 
factors, epigenetic modifications and histone variants. Some of these factors are known 
as the chromatin regulator in 1-cell stage embryos. The artificially increased level of 
HMG-I protein, which is a chromatin remodeling factor, by the injection with the 
recombinant HMG-I induced chromatin decondensation and accelerated the timing of 
minor ZGA (Beaujean et al., 2000). In addition, the elevated level of histone acetylation 
by tricostatin A, which is an inhibitor for histone deacetylases, induced to reorganize the 
chromatin structure from that of somatic cells into that of 1-cell stage embryos in 
transferred embryos with somatic nucleus (Martin et al., 2006). This report suggests that 
histone acetylases also promoted the decondensation of chromatin in 1-cell stage 
embryos. Thus, HMG-I and histone acetylases possibly induce chromatin 
decondensation during minor ZGA phase. The unique component of histone variants in 
the pronucleus at the 1-cell stage is likely also involved in the loosened chromatin 
structure. Although there are several H2A variants, only H2A.X is abundantly 
incorporated into the pronuclei of 1-cell stage embryos (Nashun et al., 2010). The H3 
variants also showed a unique pattern of the deposition in the nucleosome of 1-cell 
stage embryos: only H3.3 was incorporated in the pronuclei of 1-cell stage embryos 
(Akiyama et al., 2011). Therefore, limited species of histone variants in the nucleosome 
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of 1-cell stage embryos may also contribute to the loosen state of chromatin during the 
phase of minor ZGA. 
Minor ZGA has been interested by few people and its regulatory mechanism has 
not been studied well, since it has been thought to have no function in development. 
However, in this thesis, I have shown that minor ZGA is indispensable and regulated by 
a unique mechanism. These new findings contribute to understand the mechanism 
regulating the development and various cellular functions, because minor ZGA is the 
initiation of gene expression program regulating the entire process of development and 
cellular events.  
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Materials and methods 
 
Collection and culture of oocytes, embryos and adult tissues 
Metaphase-II-stage oocytes (oocytes) were obtained from superovulating 3-week-old 
C57BL6/J or BDF1 female mice (SLC Japan, Shizuoka) treated with 5 IU of pregnant 
mare serum gonadotropin (PMSG; ASKA Pharmaceutical Co., Tokyo) followed 48 h 
later by 5 IU of human chorionic gonadotropin (hCG; ASKA Pharmaceutical). Oocytes 
were collected from the ampullae of oviducts 15 h post-hCG injection and transferred to 
human tubal fluid medium (HTF) (Lawitts and Biggers, 1993) supplemented with 10 
mg/ml BSA (Sigma-Aldrich, Saint Louis, MO). For the oocytes of C57BL6/J female 
mice, the spermatozoa were collected from the caudal epididymides of adult C57BL6/J 
male mice (SLC Japan). When the oocytes of BDF1 female mice were inseminated, the 
spermatozoa were obtained from the caudal epididymides of adult ICR male mice (SLC 
Japan). The spermatozoa were pre-incubated for 2 h in TYH medium (Toyoda et al., 
1971) or HTF medium supplemented with 10 mg/ml BSA for the oocytes of C57BL6/J 
female mice or BDF1 female mice, respectively, in an atmosphere of 5% CO2/95% air 
at 38°C. The collected oocytes were inseminated with pre-incubated spermatozoa in 
HTF supplemented with 10 mg/ml BSA. Between four and six hours after insemination, 
the fertilized oocytes were washed and cultured in potassium simplex optimized 
medium (Quinn and Begley, 1984). The 1-cell, 2-cell, 4-cell, morula and blastocyst, 
stage embryos of C57BL6/J mice were collected at 13, 32, 48, 72, and 96 h after 
insemination, respectively. Adult tissues (kidney, heart, liver, lung, brain, and ovary) 
were obtained from 8-week-old BDF1 female mice. Testis was collected from 
8-week-old BDF1 male mice. The oocytes of BDF1 mice and the embryos developed 
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from the inseminated oocytes of BDF1 mice with the spermatozoa of ICR mice were 
subjected to most experiments, exceptionally for the preparation of RNA sequencing 
libraries. 
 
Treatment with DRB and aphidicolin 
1-cell stage embryos were transferred into KSOM containing 20, 40, 60, 80, 100, and 
120 M DRB (Sigma-Aldrich) at 4 h after insemination. Transcription was not initiated 
at 4 h after insemination (Aoki et al., 1997). When the embryos were temporary treated 
with DRB, the treated embryos were moved into KSOM without DRB at 20 or 42 h 
after insemination. This reason in detail was described in chapter I. 1-cell stage embryos 
of C57BL/6 mice were transferred into KSOM with 3 mg/ml aphidicolin 
(Sigma-Aldrich) at 16 h after insemination. The majority of the C57BL/6 mice embryos 
entered M phase at 16 h after insemination.  
 
In vitro transcription assay 
BrU was incorporated into nucleuses using in vitro transcription assay as described 
previously (Aoki et al., 1997). Plasma membrane of embryos was permeabilized with 
0.08% of Triton X-100 (Sigma-Aldrich) in a physiological buffer for 1 min at room 
temperature. After the embryos were briefly washed with a physiological buffer at three 
times, the embryos were incubated in a physiological buffer containing nucleotides and 
0.4mM BrUTP (Sigma) for 15 min at 33 ºC. The transcription reaction was terminated 
by the permeabilization of nuclear membrane in a physiological buffer containing 0.2% 
of TritonX-100 for 3 min at room temperature. The permeabilized embryos were fixed 
in a physiological buffer containing 3.7% of paraformaldehyde (Wako, Osaka, Japan) 
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for 1 hour at room temperature. The fixed embryos subjected to Immunocytochemistry 
using anti-BrdU antibody (1:50 dilution; Roche Diagonostic, Indianapolis, IN, USA), 
which has the cross reactivity against BrU, and Alexa flour 488-conjugated anti- mouse 
IgG secondary antibody (1:100 dilution; Sigma). 
 
Incorporation of BrdU 
The embryos were transferred into KSOM medium containing 10 M BrdU (Roche 
Diagonostic) at 14 h after insemination. The majority of BDF1 mice embryos were 
G2/M or M phase of 1-cell stage at 14 h after insemination. The embryos which 
incorporated BrdU were fixed in phosphate buffered saline (PBS) containing 3.7% of 
paraformaldehyde for 1 hour at room temperature. After washing with PBS containing 
1% bovine serum albumin (BSA), the fixed embryos were incubated in 2 M HCl for 1 
hour at 37 ºC. The embryos were washed in PBS containing 1% BSA and then 
neutralized in 0.1 M Tris-HCl (pH 8.5) for 15 min at room temperature. The embryos 
were subjected to Immunocytochemistry using anti-BrdU antibody (1:100 dilution) and 
Alexa flour 488-conjugated anti-mouse IgG secondary antibody (1:100 dilution; 
Sigma).  
 
Immunocytochemistry 
The embryos were fixed in PBS containing 2% paraformaldehyde for 15 min at room 
temperature. The fixed embryos were permeabilized in 0.5% Triton X-100 diluted in 
PBS for 15 min at room temperature. After the embryos were washed with PBS 
containing 1% BSA (Sigma) at three times, the permeablized embryos were incubated 
with anti-phosphorylated Ser2 of RNA polymerase II antibody (Abcam, Cambridge, 
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UK) in PBS containing 1% BSA (1:100 dilution) for 1 hour at room temperature. The 
embryos were washed with PBS containing 1% BSA and incubated with FITC 
(fluorescein)-conjugated anti-mouse IgM secondary antibody (1:100 dilution; Abcam) 
for 1 hour at room temperature. The embryos were mounted on slide glass using 
VectaShield (Vector Laboratories, Burlingame, CA, USA) supplemented with 3 mg/ml 
4',6-diamidino-2-phenylindole (DAPI; Dojindo Laboratories, Kumamoto, Japan). 
Confocal digital images were collected using a confocal laser-scanning microscope 
(LSM 5 EXCITER: Carl Zeiss MicroImaging GmbH, Oberkochen).  
 
RNA extraction and preparation of the RNA-seq library 
C57BL/6J mice of oocytes and embryos were subjected to RNA extraction for RNA 
sequencing. Total RNA was extracted from 3,000 of oocytes, 3,000 of 1-cell stage 
embryos, 4,500 of 2-cell stage embryos, 2,800 of 4-cell stage embryos, 1,400 of 
morulas and 700 of blastocysts, using Isogen (Nippon Gene, Tokyo, Japan), according 
to the manufacturer’s instructions. The quality of RNA was verified on the Bioanalyzer 
RNA Pico Chip (Agilent Technologies, Santa Clara, CA). RNA-Seq libraries were 
constructed using the mRNA-Seq Sample Preparation Kit (Illumina, San Diego, CA) 
without selection of polyadenylated RNA.  
 
Sequencing and mapping of RNA-seq reads on the mouse genome   
RNA-seq libraries were subjected to sequencing using Genome Analyzer IIx (Illumina). 
The 35-nt single-end sequencing reads were mapped onto the mouse genome reference 
sequence (mm9, UCSC Genome Browser) allowing for no mismatch using the ELAND 
software (Table 1). The uniquely mapped reads on RefSeq genes were used to calculate 
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RPKM values of RefSeq genes in each sample. The results of RNA-seq data analysis 
were visualized on the genome browser using the Genome Studio software (Illumina). 
To analyze intergenic regions, 76-nt paired-end-sequencing reads were mapped onto 
mouse genome reference sequences (mm9) allowing 1- or 2-nt mismatches using the 
GSNAP software (Wu and Nacu, 2010). These mapped 76-nt reads (excluding those on 
rRNA and tRNA genes) were used to construct sequence fragments for each pair of 
reads (Table 2). To adjust the number of fragments used for sample analysis, 18 million 
fragments were randomly selected from each sample. To collect the fragments that 
mapped to intergenic regions, we removed fragments that overlapped with gene regions 
annotated in RefSeq and Ensemble. 
 
k-mean nonhierarchical clustering 
Relative expression levels were calculated by RPKM values in oocytes, 1- and 2-cell 
stage embryos. The average RPKM values between oocytes, 1- and 2-cell stage 
embryos were set as 1. The relative expression values were converted into log10 values 
and subjected to k-mean nonhierarchical clustering using TIGR Multiple Experiment 
Viewer (MeV) (Saeed et al., 2003). 
 
Reverse transcription and polymerase chain reaction 
Total RNA was isolated from 100 oocytes and embryos using Isogen (Nippon Gene), 
and was prepared for reverse-transcription using a PrimeScript RT-PCR kit (Takara Bio 
Inc., Otsu), according to the manufacturer’s instructions. PCR was performed in a 
thermal cycler (iCycler; Bio-Rad, Berkeley, CA) using Ex Taq DNA polymerase 
(Takara) and following described primer pairs: intergenic-1: 
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5’-GCATTGTCCCTTGATTCAGC-3’ and 5’-CCAAGCAAGGCTTTGTGAA-3’, 
intergenic-2: 5’-ACCCTCAAGCACCTTTCCTT-3’ and 
5’-AGCAGATGCCCAGCATAAAC-3’, linc-1: 5’-CAGGCATTGCACAACTCAAG-3’ 
and 5’-GAGCAACGAGAGCCAAGTTT-3’, linc-2: 
5’-CCTGAACAACAAAAGCAGCA-3’ and 5’-GCTTCAGGCTGGTAGACTGG-3’, 
linc-3: 5’-AGTGCCTTGCTGCATTGTTCATCT-3’ and 
5’-TGCCAAGAGGCTGGCTTCCTA-3’, linc-4: 5’-TAATGTCACATGCCCTTGGA-3’ 
and 5’-GGGCACTTAGCAAGAACCAC-3’, GAPDH: 
5’-ACCACAGTCCATGCCATCAC-3’ and 5’-TCCACCACCCTGTTGCTGTA-3’, and 
Rabbit -globin: 5’-GTGGGACAGGAGCTTGAAAT-3’ and 
5’-GCAGCCACGGTGGCGAGTAT-3’. The PCR conditions were following programs: 
GAPDH: 32 cycles of 95ºC for 30 s, 60ºC for 30 s, and 72ºC for 60 s. Rabbit -globin: 
26 cycles of 95ºC for 30 s, 58ºC for 30 s, and 72ºC for 60 s. Other primers: 38 cycles of 
95ºC for 30 s, 60ºC for 30 s, and 72ºC for 60 s.  
 
Microinjection of LNA-DNA gapmers 
The embryos were transfer to HEPES-buffered KSOM between 2 and 4 h after 
insemination and injected into the cytoplasm of 1-cell stage embryos with LNA-DNA 
gapmers which were diluted in nuclease-free water to 10 M. LNA-DNA gapmers were 
purchased from Gene Design (Osaka, Japan): the sequences were as shown in Table 3. 
 
Sequence information of core promoter elements and collection of G/C-rich regions 
in intergenic regions 
Sequences of core promoter elements were referred to (Smale and Kadonaga, 2003). 
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G/C-rich regions in intergenic region were collected from the list of 50 bp sequences 
that were created by the 50 bp sliding window analysis with a 25 bp-shift. The regions 
of over 60% G/C contents in the list of 50 bp sequences were categorized as G/C-rich 
regions. Refseq and Ensemble annotated genes, CpG islands and these 2 kb up- and 
downstream regions were removed from the list of G/C-rich regions. Next to or 
overlapped G/C-rich regions with each others were regarded as one region and 
combined with each other. When G/C-rich regions were mapped within 1 kb of each 
other, these regions were removed from the list of G/C-rich regions. 
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